DK1144420T3 - Sulfaterede phosphatidylinositoler, fremgangsmåde til fremstilling heraf og anvendelser heraf - Google Patents

Sulfaterede phosphatidylinositoler, fremgangsmåde til fremstilling heraf og anvendelser heraf

Info

Publication number
DK1144420T3
DK1144420T3 DK00903264T DK00903264T DK1144420T3 DK 1144420 T3 DK1144420 T3 DK 1144420T3 DK 00903264 T DK00903264 T DK 00903264T DK 00903264 T DK00903264 T DK 00903264T DK 1144420 T3 DK1144420 T3 DK 1144420T3
Authority
DK
Denmark
Prior art keywords
sulfated
pharmaceutical compositions
phosphatidylinositols
preparation
sulfated phosphatidylinositol
Prior art date
Application number
DK00903264T
Other languages
Danish (da)
English (en)
Inventor
Eric J Dadey
Xiao-Hui Mei
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Application granted granted Critical
Publication of DK1144420T3 publication Critical patent/DK1144420T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK00903264T 1999-01-15 2000-01-12 Sulfaterede phosphatidylinositoler, fremgangsmåde til fremstilling heraf og anvendelser heraf DK1144420T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11616699P 1999-01-15 1999-01-15
PCT/US2000/000749 WO2000042050A1 (fr) 1999-01-15 2000-01-12 Phosphatidylinositols sulfates, leur preparation et utilisation

Publications (1)

Publication Number Publication Date
DK1144420T3 true DK1144420T3 (da) 2004-04-13

Family

ID=22365644

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00903264T DK1144420T3 (da) 1999-01-15 2000-01-12 Sulfaterede phosphatidylinositoler, fremgangsmåde til fremstilling heraf og anvendelser heraf

Country Status (12)

Country Link
US (1) US6316424B1 (fr)
EP (1) EP1144420B1 (fr)
JP (1) JP2002534528A (fr)
AT (1) ATE256134T1 (fr)
AU (1) AU2503900A (fr)
BR (1) BR0007513A (fr)
CA (1) CA2356306C (fr)
DE (1) DE60007074T2 (fr)
DK (1) DK1144420T3 (fr)
ES (1) ES2214249T3 (fr)
PT (1) PT1144420E (fr)
WO (1) WO2000042050A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020065927A1 (en) 2000-09-05 2002-05-30 Janik Craig M. Webpad and method for using the same
US20050084513A1 (en) * 2003-10-21 2005-04-21 Board Of Regents Nanocoating for improving biocompatibility of medical implants
US20050239747A1 (en) * 2004-04-21 2005-10-27 Pharmaceutical Industry Technology And Development Center Compositions and methods of enhanced transdermal delivery of steroid compounds and preparation methods
TW200846031A (en) * 2007-05-25 2008-12-01 Shu-Yi Lin Drug delivery system and the preparing method thereof
WO2009078820A1 (fr) * 2007-12-18 2009-06-25 Agency For Science, Technology And Research Nanoparticules peptidiques cationiques à noyau-enveloppe
US8715987B2 (en) * 2011-05-02 2014-05-06 New England Biolabs, Inc. Solubilized phospholipids for stabilizing nucleic acid polymerases
CN108586574B (zh) * 2018-04-26 2019-11-12 国家海洋局第三海洋研究所 氨基葡萄糖肽类化合物及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0293826A3 (fr) * 1987-06-02 1989-05-10 Stichting REGA V.Z.W. Application thérapeutique et prophylactique des polysaccharides sulfatés contre le SIDA
US5194654A (en) * 1989-11-22 1993-03-16 Vical, Inc. Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
US6602861B1 (en) * 1992-04-16 2003-08-05 Research Corporation Technologies, Inc. Acylated phospholipid drugs
JP4099234B2 (ja) * 1996-05-16 2008-06-11 日清食品株式会社 抗ウイルス活性を有する新規化合物

Also Published As

Publication number Publication date
JP2002534528A (ja) 2002-10-15
PT1144420E (pt) 2004-04-30
DE60007074D1 (de) 2004-01-22
BR0007513A (pt) 2001-11-20
ES2214249T3 (es) 2004-09-16
WO2000042050A1 (fr) 2000-07-20
AU2503900A (en) 2000-08-01
EP1144420B1 (fr) 2003-12-10
CA2356306A1 (fr) 2000-07-20
ATE256134T1 (de) 2003-12-15
US6316424B1 (en) 2001-11-13
DE60007074T2 (de) 2004-09-16
EP1144420A1 (fr) 2001-10-17
CA2356306C (fr) 2006-02-21

Similar Documents

Publication Publication Date Title
NZ501950A (en) Medicinal compositions for application to mucosa
ATE235895T1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
IS1694B (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
PT693924E (pt) Processos para administracao (in vivo) de substancias biologicas e composicoes utilizadas nestes processos
DE69940674D1 (de) Orale verabreichung von adenosin analogen
RS49803B (sr) Primena lekovitih preparata rastvorenih u vodi za dobijanje aerosolova bez potisnog gasa
HUP0101293A2 (hu) AspB28-humán inzulint tartalmazó inhalációs gyógyászati készítmény és alkalmazása
DK0781281T3 (da) Beta-Carbolinderivater som melatonin-agonister, fremgangsmåder til fremstilling deraf og deres anvendelse som lægemiddel
DK1365749T3 (da) Fremgangsmåde til fremstilling af farmaceutiske sammensætninger til anvendelse i blöde gelformuleringer
DK0934058T3 (da) Stabil lægemiddelform med benzimidazolderivater som aktivt stof til oral indgivelse og fremgangsmåde til fremstilling deraf
ATE292453T1 (de) Antivirale arznei
CA2282082A1 (fr) Microgranules contenant du cisplatine
DK0994887T3 (da) Modificerede glycosider, præparater omfattet deraf og fremgangsmåder til anvendelse deraf
DK1144420T3 (da) Sulfaterede phosphatidylinositoler, fremgangsmåde til fremstilling heraf og anvendelser heraf
EA200200914A1 (ru) Система контроля дозирования для однократного ежедневного приема назначенного ципрофлоксацина
DE60316714D1 (de) Pharmazeutische formulierung enthaltend olanzapin
DE59708495D1 (de) Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung
MY100780A (en) Azumolene dosage form.
GEP20043377B (en) Pharmaceutical Complex
ATE234096T1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
GB9917290D0 (en) Pharmaceutical composition
MY102368A (en) Solid sustained-release composition